San Diego-centered Viking Therapeutics marked alone as a significant competitor during the weight loss drug current market in February immediately after revealing promising info from the mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when given as a weekly injection As well as in M